By Jill Colvin and Alexandra Jaffe

President-elect Joe Biden on Monday received his first dose of the coronavirus vaccine on live television as part of a growing effort to convince the American public the inoculations are safe.

The president-elect took a dose of Pfizer vaccine at a hospital not far from his Delaware home, hours after his wife, Jill Biden, did the same. The injections came the same day that a second vaccine, produced by Moderna, will start arriving in states. It joins Pfizer's in the nation's arsenal against the COVID-19 pandemic, which has now killed more than 317,000 people in the United States and upended life around the globe.

“I'm ready,” said Biden, who was administered the dose at a hospital in Newark, Delaware, and declined the option to count to three before the needle was inserted into his left arm. “I’m doing this to demonstrate that people should be prepared when it’s available to take the vaccine. There’s nothing to worry about.”

The president-elect praised the health care workers and said President Donald Trump's administration “deserves some credit getting this off the ground.” And Biden urged Americans to wear masks during the upcoming Christmas holiday and not travel unless necessary.

Other top government officials last week joined the first wave of Americans to be inoculated against COVID-19 as part of the largest largest vaccination campaign in the nation's history.

Vice President Mike Pence, House Speaker Nancy Pelosi, D-Calif., Senate Majority Leader Mitch McConnell, R-Ky., and other lawmakers were given doses Friday. They chose to publicize their injections as part of a campaign to convince Americans that the vaccines are safe and effective amid skepticism, especially among Republicans.

Vice President-elect Kamala Harris and her husband are expected to receive their first shots next week.

But missing from the action has been President Donald Trump, who has spent the last week largely out of sight as he continues to stew about his election loss and floats increasingly outlandish schemes to try to remain in power. It's an approach that has bewildered some top aides who see his silence as a missed opportunity for the president, who leaves office Jan. 20, to claim credit for helping oversee the speedy development of the vaccine and to burnish his legacy.

Trump, who in the past has spread misinformation about vaccine risks, has not said when he intends to get the shot. He tweeted earlier this month that he was “not scheduled” to take it, but said he looked “forward to doing so at the appropriate time.”

The White House has said he is still discussing timing with his doctors.

Trump was hospitalized with COVID-19 in October and given an experimental monoclonal antibody treatment that he credited for his swift recovery. A Centers for Disease Control and Prevention advisory board has said people who received that treatment should wait at least 90 days to be vaccinated to avoid any potential interference.

“When the time is right, I’m sure he will remain willing to take it,” White House spokesperson Brian Morgenstern echoed Friday. “It’s just something we’re working through.”

White House press secretary Kayleigh McEnany, however, offered a different explanation for the delay. She told reporters last week that Trump was holding off, in part, “to show Americans that our priority are the most vulnerable.”

“The President wants to send a parallel message, which is, you know, our long-term care facility residents and our frontline workers are paramount in importance, and he wants to set an example in that regard,” she said.

The CDC's Advisory Committee on Immunization Practices has said the Pfizer-BioNTech vaccine, which was the first to receive authorization, “is safe and likely efficacious" for people who have been infected with COVID-19 and “should be offered regardless of history of prior symptomatic or asymptomatic SARS-CoV-2 infection.”

While there is no recommended minimum wait time between infection and vaccination, because reinfection is uncommon in the three months after a person is infected, the committee said people who tested positive in the preceding 90 days "may delay vaccination until near the end of this period, if desired.”

The panel also recommends that those who received Trump's treatment put off vaccination for at least 90 days.

“Currently, there are no data on the safety and efficacy of Pfizer-BioNTech COVID-19 vaccination in persons who received monoclonal antibodies or convalescent plasma as part of COVID-19 treatment," they wrote, recommending that vaccination "be deferred for at least 90 days, as a precautionary measure until additional information becomes available, to avoid interference of the antibody treatment with vaccine-induced immune responses.”

Surgeon General Jerome Adams cited that recommendation on CBS’s “Face the Nation” on Sunday when asked if Trump planned to receive the shot on camera.

“From a scientific point of view, I will remind people that the president has had COVID within the last 90 days. He received the monoclonal antibodies. And that is actually one scenario where we tell people maybe you should hold off on getting the vaccine, talk to your health provider to find out the right time,” Adams said.

But others, including Dr. Anthony Fauci, the nation’s top infectious diseases expert, have recommended that Trump be vaccinated without delay.

“Even though the president himself was infected, and he has, likely, antibodies that likely would be protective, we’re not sure how long that protection lasts. So, to be doubly sure, I would recommend that he get vaccinated,” he told ABC News.

___

Colvin reported from Washington. Associated Press writer Jonathan Lemire in New York contributed to this report.

Share:
More In Politics
New Rules for International Travelers When U.S. Lifts COVID Restrictions
Beginning in November, fully vaccinated international travelers will be able to enter the United States after months of travel restrictions. People under the age of 18 and those from countries without easy access to vaccines will not be required to be vaccinated but all travelers will need to show negative COVID test results before entering.
Apple Likely to Face Antitrust Lawsuit From Justice Department
Apple could soon face a Department of Justice antitrust lawsuit after intensifying its probe into the tech giant, according to a report. The added scrutiny comes after the tech giant had already faced questioning in Washington and concluded an antitrust case brought by Epic Games.
SPAC Linked to President Trump Sees Massive Boom
Last week, shares of Digital World Acquisition Corp skyrocketed after following Former Present Trump's announcement that he would be partnering with the company as part of a Special Purpose Acquisition Company, or SPAC. Christian Munafo, Chief Investment Officer of Liberty Street Advisors and portfolio Manager of the Private Shares Fund broke down the latest, including whether or not Wall Street is currently experiencing a SPAC boom.
Dow, S&P 500 Hit Record Close as Stocks End Monday Higher
Stocks began the week on a high note, with two indexes - the Dow and the S&P 500 - each closing at a record high. Brian Levitt, Global Market Strategist at Invesco, joins Cheddar News' Closing Bell, where he explains why the conditions were in place for a jump during the session and provides insight on inflation concerns in the United States.
Evaluating Future Path for Cryptocurrencies as Bitcoin ETFs Go Public
The price of Bitcoin hit a new all-time high last week following the Wall Street debut of ProShares Bitcoin Strategy ETF. Todd Cipperman, Founding Principal for Cipperman Compliance Services, joins Cheddar News' Closing Bell, where he explains why ProShares' ETF got off to a hot start while Valkyrie's Bitcoin Strategy ETF, which debuted just days later, did not.
Facebook Criticisms Reach 'Boiling Point' With Calls for New Laws, Investigation
Rishi Bharwani, the director of partnerships and policy for nonprofit Accountable Tech, joined Cheddar to discuss the hot button topic of regulatory oversight of social media giant Facebook. Bharwani discussed the bipartisan pieces of legislation already making their way through Congress and said the body should pass stronger data privacy laws, ban surveillance advertising, and require meaningful accountability and transparency from the company. "Now I think we've reached a boiling point where congressional action is needed and inaction is no longer acceptable," he said. Bharwani also called for a concurrent investigation into Mark Zuckerberg's company.
Siemens U.S. CEO Calls for Large Climate Commitments at COP26 Talks
The United Nations COP26 climate talks are scheduled for October 31 to November 12 in Glasgow, Scotland. Heads of state will be joined by private sector leaders to once again discuss the shrinking window of time left to take action against global temperature rise. Barbara Humpton, CEO of focused technology company Siemens U.S., is also attending and spoke to Cheddar about what she hopes to see during the conference for both the public and private spheres. "What we are really urging is that there are large commitments made in Glasgow and that we really commit to this next decade of action," she said.
Supreme Court to Review Texas Abortion Law in November
Jessica Mason Pieklo, Senior Vice President and Executive Editor at Rewire News Group and co-host of the Rewire News Group podcast, 'Boom! Lawyered,' joins Cheddar News to discuss the Supreme Court decision to hear Texas abortion ban cases on Monday, November first and the complicated timeline of legal challenges up to this point.
Load More